Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| HSBC Holdings | 1.77% | $15.96M | £212.42B | 49.75% | 80 Outperform | |
| Barclays | 1.46% | $13.18M | £66.95B | 68.98% | 78 Outperform | |
| Novartis AG | 1.30% | $11.69M | CHF217.88B | 29.42% | 80 Outperform | |
| GlaxoSmithKline | 1.27% | $11.41M | £74.55B | 35.98% | 77 Outperform | |
| Standard Chartered | 1.24% | $11.14M | £41.75B | 96.50% | 77 Outperform | |
| ING GROEP | 1.17% | $10.57M | €70.85B | 57.02% | 61 Neutral | |
| Roche Holding AG | 0.99% | $8.95M | CHF276.02B | 52.12% | 73 Outperform | |
| ArcelorMittal | 0.99% | $8.93M | €31.34B | 86.34% | 73 Outperform | |
| ― | 0.97% | $8.71M | ― | ― | ― | |
| Murata Manufacturing Co | 0.94% | $8.51M | ¥6.27T | 37.26% | 77 Outperform |